News | Stents Bifurcation | March 31, 2017

Tryton Medical Announces First U.S. Commercial Case with Tryton Side Branch Stent

Patient with coronary bifurcation lesion involving large side branch treated with first dedicated bifurcation stent to receive regulatory approval in the U.S.

Tryton Medical, Side Branch Stent, first U.S. commercial case, New York-Presbyterian Hospital, Columbia University Medical Center

March 31, 2017 — Tryton Medical Inc. recently announced that the first U.S. commercial case using the Tryton Side Branch Stent was completed at New York-Presbyterian Hospital/Columbia University Medical Center in New York City. The device was used to treat a coronary bifurcation lesion involving a large side branch (appropriate for a ≥2.5mm stent) in a procedure performed by Martin Leon, M.D., director of the Center for Interventional Vascular Therapy, and Ajay Kirtane, M.D., SM, director of the Cardiac Catheterization Laboratory.

Watch a VIDEO demonstration of the deplyment for the Tryton Dedicated Bifurcation Stent.

pproximately 20-30 percent of all patients undergoing percutaneous coronary interventions (PCI) to open blocked arteries have a bifurcation lesion. The Tryton Side Branch Stent recently became the first dedicated bifurcation stent to receive regulatory approval in the United States. Tryton has signed a strategic distribution agreement with Cardinal Health enabling Cordis, its interventional vascular business, to be the exclusive distributor of the Tryton Side Branch Stent in the U.S.

The Tryton Side Branch Stent System is built using proprietary Tri-Zone technology to offer a dedicated strategy for treating bifurcation lesions. Tryton’s cobalt chromium stent is deployed in the side branch artery using a standard single wire balloon-expandable stent delivery system. A conventional drug-eluting stent is then placed in the main vessel.

Read the article "FDA Clears First Dedicated Coronary Bifurcation Stent."

For more information: www.trytonmedical.com


Related Content

News | ACC

May 26, 2023 — The Clinical Hospital of Emergency Services, a municipal hospital serving the community of Dnipro, in ...

Home May 26, 2023
Home
News | ACC

April 11, 2023 — A newly-published study in the Journal of the American College of Cardiology, JACC, the flagship ...

Home April 11, 2023
Home
News | ACC

March 21, 2023 — As part of its extensive coverage, the editorial team at dicardiology.com/DAIC has shared summary ...

Home March 21, 2023
Home
News | ACC

March 16, 2023 — The American College of Cardiology (ACC) announced the winners and finalists of its 2023 Young ...

Home March 16, 2023
Home
News | ACC

March 12, 2023 — As part of its ongoing news coverage of ACC23, the DAIC/dicardiology.com editorial team has condensed ...

Home March 12, 2023
Home
News | ACC

March 9, 2023 — C. Noel Bairey Merz, MD, FACC, professor of cardiology and the director of the Barbra Streisand Women’s ...

Home March 09, 2023
Home
News | ACC

March 9, 2023 — Positive results from a Mineralys Therapeutics study, the Target-HTN Phase 2 trial, demonstrated ...

Home March 09, 2023
Home
News | ACC

March 8, 2023 — B. Hadley Wilson, MD, FACC, is the new president of the American College of Cardiology. Today marks the ...

Home March 08, 2023
Home
News | ACC

March 6, 2023 — In findings presented from the STELLAR Phase III Trial during the American College of Cardiology’s 2023 ...

Home March 06, 2023
Home
News | ACC

March 7, 2023 — A virtual care team-guided strategy for guideline-directed medical therapy (GDMT) optimization was found ...

Home March 06, 2023
Home
Subscribe Now